Candriam SCA’s Lydall, Inc. LDL Stock Holding History

Candriam SCA’s Portfolio LDL Stock Details LDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-101,884	Closed	-$6.33M	–	915
2021 Q3	$6.33M	Buy	101,884 +2,686	+3%	+$165K	0.04%	350
2021 Q2	$6M	Buy	+99,198	New	+$3.82M	0.04%	371

Candriam SCA's LDL Position: Q4 2021 in Review

Candriam SCA sold out of Lydall, Inc. (LDL) in Q4 2021, closing a stake of 101,884 shares — an estimated $6.33M sold.

Candriam SCA first reported a position in LDL in Q2 2021 and held it in 2 quarters. The position peaked at $6.33M in Q3 2021. 1 fund tracked by Wall St. Rank holds LDL as of Q4 2021.

Candriam SCA reported no remaining Lydall, Inc. position as of Q4 2021 after selling out during the quarter.
Candriam SCA sold 101,884 Lydall, Inc. shares in Q4 2021, an estimated $6.33M.
Candriam SCA first reported a position in Lydall, Inc. in Q2 2021 and held it in 2 quarters.
Candriam SCA's Lydall, Inc. position peaked at $6.33M in Q3 2021.
1 fund tracked by Wall St. Rank held Lydall, Inc. as of Q4 2021.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.